Search

everythinglearnresearchcommunity

for

Search:↓

A 77-year-old woman with hair loss had high testosterone and 17OH-progesterone levels, but no significant findings on imaging.

Hirsutism in women is mostly caused by polycystic ovary syndrome and idiopathic hyperandrogenism.

PCOS is a common hormonal disorder with symptoms like irregular periods and excess hair growth, managed with lifestyle changes and medications.

Metformin improved menstrual cycle regularity and signs of hyperandrogenism in adolescent girls with type 1 diabetes but did not improve blood sugar control.

Topical minoxidil helps transgender individuals assigned female at birth grow more facial hair.

Treating excessive hair in women requires a holistic approach, including medical, aesthetic, and emotional support.

Finasteride reduces hair growth better, but spironolactone has more side effects.

Spironolactone plus finasteride reduces hirsutism more effectively.

Taking 100 mg of DHEA daily for 16 weeks did not change metabolic and reproductive health significantly but increased certain ovarian markers with minimal side effects.

Finasteride effectively reduces hair growth in women with idiopathic hirsutism, but requires careful contraception during treatment.

Most cases of excessive hair growth in women are caused by polycystic ovarian syndrome and are linked to higher free testosterone levels.

Laser hair removal is effective for hirsutism when combined with treatment for the underlying causes.

Curcumin improved some metabolic factors in women with PCOS but did not affect cholesterol, insulin, or testosterone levels.

Women with hyperandrogenic amenorrhea have similar bone density to healthy women but lower than androgenized women without amenorrhea, and high DHEAS levels might affect bone density.

Spironolactone most effective for hirsutism, but has side effects.

Finasteride effectively treats hirsutism in women, but more research needed for long-term results.

Adults can develop late-onset loose anagen syndrome, which may often be misdiagnosed.

Blood tests can detect ovarian Leydig cell tumors when scans don't, and surgery can confirm and treat these tumors.

Hirsutism in women is often due to hormone sensitivity and has significant psychological effects.

The woman's rare combination of diseases suggests an unknown factor may predispose individuals to multiple endocrine diseases.

PCOS treatment focuses on lifestyle changes and specific medications to manage symptoms and complications.

Ovarian vein sampling helped diagnose rare ovarian tumors causing high testosterone, and surgery to remove the tumors lowered the testosterone levels.

A woman's male-pattern facial hair growth was caused by a rare malignant ovarian tumor that was difficult to diagnose and treat.

Benign ovarian tumors can cause excess male hormones and related conditions in postmenopausal women.

Finasteride reduces hirsutism effectively with fewer side effects but is a second-choice treatment due to safety concerns.

Methotrexate treatment for rheumatoid arthritis has a serious infection rate of about two per 100 patient-years.

A woman's masculine symptoms were caused by a rare tumor in her left ovary, which was found using a special blood test.

5α-reductase inhibitors like finasteride may not be effective or safe for transgender individuals, and more research is needed.

Hirsutism and acanthosis nigricans are reliable skin signs of PCOS linked to metabolic issues, while acne is not a reliable marker of the condition.

Women with PCOS often have more hair growth, skin darkening, and acne, which are linked to hormonal and metabolic issues.